Present and future-looking investor data is collected and curated by LSN’s Investor Research team through ongoing dialogue with 5000 life science investors from around the world, identifying their investment mandates.
The LSN Company Platform is the premier life science company database, covering over 30,000 companies around the world, with a particular focus on the bottom third of the market that is missed by traditional data providers.
Redefining Early Stage Investments is an ongoing conference series establishing a global circuit for early stage life sciences companies to source investors, create relationships, and eventually, get funding.
Life Science Nation (LSN) has created a funding and partnering platform for early-stage life science companies in biotech, medtech, diagnostics and digital health that is unique to the industry. The platform consists of two databases, one tracks emerging life science companies and the other curates investors from around the world who are funding these entities. Augmenting these two platforms is the Redefining Early Stage Investments (RESI) Conference series and an I-Bank, Boston Innovation Capital (BIC) that help facilitate the matching up of buyers and sellers.